In conclusion, plasma levels of three putative novel AKI mediators (TWEAK, Ang-2, PTX3) in critically ill patients are not affected by CVVH, since clearance and absorption by the filter were low. The gene discussed is ANGPT2; the disease is acute kidney injury.